At a Make America Healthy Again summit, Health Secretary Robert F. Kennedy Jr. announced a federal effort to help patients taper off commonly used antidepressants, focusing attention on selective serotonin reuptake inhibitors (SSRIs) such as Prozac, Zoloft, Lexapro and Paxil. Kennedy framed the issue as a ‘dependency crisis driven by overmedicalization’ and pledged new training, clinical guidance and insurance changes to support people who want or need to stop these medications.
Many psychiatrists and mental health advocates say that description simplifies a complex problem and overlooks the bigger gap in access to comprehensive care. ‘It really is an oversimplification,’ said Dr. Theresa Miskimen Rivera, president of the American Psychiatric Association. Rivera and the APA support better training for clinicians on safe prescribing and tapering, but they stress that many patients lack timely, coordinated mental health services in the first place.
Kennedy has previously made unsubstantiated claims linking psychiatric drugs to mass shootings. His new initiative, however, focuses on practical steps: the Substance Abuse and Mental Health Services Administration will publish new prescribing data and clinical guidance, and the Centers for Medicare & Medicaid Services plans billing guidance to facilitate medically supervised tapering and to expand access to evidence-based alternatives like therapy and family support for children.
A Department of Health and Human Services ‘Dear Colleague’ letter acknowledged the role psychiatric medications can play in reducing symptoms, improving functioning, preventing relapse and supporting recovery, while urging that medications not be the only treatment option and encouraging shared decision-making between patients and providers.
Child and adolescent psychiatrist Dr. Vera Feuer of the Child Mind Institute said several recommendations are reasonable: perform detailed assessments, avoid medicating behaviors better addressed by other interventions, and provide medically supervised tapering when appropriate. Feuer noted that only a minority of children with mental health conditions require medication and that talk therapy works for many, although access to therapy is often limited. She also emphasized that SSRIs have helped many families by improving a child’s functioning.
The American Foundation for Suicide Prevention reiterated the importance of antidepressants for people with major depression and suicidality, citing decades of research that, when used judiciously, antidepressants treat acute depression, help prevent future episodes and reduce suicidal thoughts and behaviors; overall, antidepressant use has been associated with a reduced suicide risk despite potential side effects.
There is broad agreement on the need for improved informed consent, greater access to nonpharmacologic treatments, and safe, supervised tapering protocols. But experts caution that framing the mental health crisis primarily as a problem of overprescribing risks ignoring the central issue: limited access to comprehensive, timely care for many patients.